Sequential multidrug chemotherapy (CHOP-VA-MB) in patients with high-grade non-Hodgkin’s lymphoma—a 20-year follow-up

被引：0
|
作者：
M. Björkholm
F. Celsing
E. Johansson
机构：
[1] Department of Medicine,
[2] Division of Hematology,undefined
[3] Karolinska Institutet and Karolinska University Hospital,undefined
来源：
Annals of Hematology | 2006年 / 85卷
关键词：
Doxorubicin; Vincristine; Bleomycin; Complete Remission Rate; Aggressive Lymphoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：731 / 733
页数：2
相关论文
共 50 条
  • [21] Natural History of CNS Relapse in Patients With Aggressive Non-Hodgkin's Lymphoma: A 20-Year Follow-Up Analysis of SWOG 8516-The Southwest Oncology Group
    Bernstein, Steven H.
    Unger, Joseph M.
    LeBlanc, Michael
    Friedberg, Jonathan
    Miller, Thomas P.
    Fisher, Richard I.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (01) : 114 - 119
  • [22] Long-term follow-up of patients with intermediate or high-grade non-Hodgkin lymphoma treated with a combination of cyclophosphamide, epirubicin, vincristine, and prednisone
    Rossini, F
    Terruzzi, E
    Perego, D
    Miccolis, I
    Rivolta, F
    Manca, E
    Pogliani, EM
    CANCER, 2004, 100 (02) : 350 - 355
  • [23] Primary non-Hodgkin’s lymphoma of the breast: eight-year follow-up experience
    Hai-Yi Guo
    Xin-Min Zhao
    Jin Li
    Xi-Chun Hu
    International Journal of Hematology, 2008, 87 : 491 - 497
  • [24] Primary non-Hodgkin's lymphoma of the breast: eight-year follow-up experience
    Guo, Hai-Yi
    Zhao, Xin-Min
    Li, Jin
    Hu, Xi-Chun
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2008, 87 (05) : 491 - 497
  • [25] Prognostic factors and long follow-up in non-Hodgkin's lymphoma
    Llanos, M
    Cruz, J
    Oramas, J
    Aleman, R
    Dorta, J
    Morales, M
    Batista, N
    ANNALS OF ONCOLOGY, 1998, 9 : 110 - 111
  • [26] Follow-up FDG PET/CT in Patients With Non-Hodgkin Lymphoma
    Taghipour, Mehdi
    Marcus, Charles
    Nunna, Pratyusha
    Subramaniam, Rathan M.
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (02) : E93 - E97
  • [27] MACOP-B CHEMOTHERAPY AND CONSOLIDATION RADIOTHERAPY IN PATIENTS WITH ADVANCED HIGH-GRADE NON-HODGKIN LYMPHOMA
    KNEBA, M
    WELLENHOFER, K
    NAGEL, GA
    KRIEGER, G
    BLUT, 1987, 55 (04): : 332 - 332
  • [28] LONG-TERM FOLLOW UP OF BNLI STUDY OF CHOP CHEMOTHERAPY IN PATIENTS WITH ADVANCED HIGH-GRADE NON-HODGKINS LYMPHOMA
    HUDSON, GV
    LINCH, DC
    HUDSON, BV
    BENNETT, MH
    MACLENNAN, KA
    ANDERSON, L
    BRITISH JOURNAL OF CANCER, 1990, 61 (01) : 168 - 168
  • [29] Long term follow-up of a phase II study of Rituximab in combination with CHOP chemotherapy in patients with previously untreated aggressive non-Hodgkin's lymphoma (NHL).
    Vose, JM
    Link, BK
    Grossbard, ML
    Czuczman, M
    Grillo-Lopez, A
    Benyunes, M
    Gaynor, E
    Fisher, RI
    BLOOD, 2002, 100 (11) : 361A - 361A
  • [30] Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate-and high-grade non-Hodgkin's lymphoma
    Miller, TP
    Dahlberg, S
    Cassady, JR
    Adelstein, DJ
    Spier, CM
    Grogan, TM
    LeBlanc, M
    Carlin, S
    Chase, E
    Fisher, RI
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (01): : 21 - 26
12345